Inventory increased 37.0%
Inventory changed +37.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +37.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +925 basis points from the comparable as-filed period.
Gross margin changed +702 basis points from the comparable as-filed period.
Inventory / revenue changed +866 basis points from the comparable as-filed period.
Gross profit changed +26.4% from the comparable as-filed period.
Operating income changed +1176.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Revenue changed +8.8% from the comparable as-filed period.
Research & development changed +13.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -20.3% from the comparable as-filed period.
Net income changed +983.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
SBC / revenue changed -161 basis points from the comparable as-filed period.
Cash & equivalents changed +2.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.